Tissue-resident immune cells are known to be derived from their circulating precursors and migrate to tissues for host defense. Recent studies have revealed heterogeneity in the origin and proliferation properties of macrophages, which are a prototype tissue-resident immune cell. The tissue-resident macrophages can originate from embryonic and fetal sources and are selfmaintained by continuous local self-renewal. 1,2 As accessory cells, tissue-resident macrophages support parenchymal cells (their 'client cells'), and their functions range from tissue development to tissue homeostasis (for example, osteoclasts, lung macrophages, microglia, splenic red-pulp macrophages, and Kupffer cells). Although macrophages are known as the major immune cell with tissue-specific functions, new frameworks integrating the functions of other immune cells with the maintenance of tissue homeostasis will be likely established in the near future.
The transcriptional master regulators (for example, PU.1 and C/EBP-β) determine the macrophage lineage before the cells enter tissues. 3, 4 These master regulators control a universal transcription module that determines the phenotype shared by all macrophage subsets. In adults, tissue-resident macrophages are differentiated from monocytes that migrate from the bone marrow via blood vessels. The cells obtain their identity by cooperation between macrophagelineage-differentiation factors (for example, M-CSF and GM-CSF) and tissue-specific factors that include environmental signals such as tissue trophic factors or functional demands. For example, heme and retinoic acid drive the differentiation of splenic red-pulp macrophages and peritoneal macrophages via the transcription factors Spi-C and GATA-6, respectively. [5] [6] [7] In addition, the alveolar macrophage is differentiated from fetal monocytes by the GM-CSF-PPAR-γ axis. 8 However, beside these few specific cases the tissue-specific signals required for tissue macrophage differentiation have not been elucidated.
Tissue-resident macrophages continuously monitor endogenous and exogenous changes to maintain tissue homeostasis. Thus, these cells play a crucial role in balancing immune protection and immune tolerance. Immune protection is especially important in host defense against invading pathogens and tumor formation. Tolerance is indispensable for inhibition of immunopathology and autoimmunity. Interestingly, homeostatic programs of tissue resident-macrophages seem to be exploited by cancer cells. 3 One wellknown example is that tumorassociated macrophages create a tumor microenvironment favoring tumor growth. Recent studies by Anandasabapathy and colleagues reported a factor critical in maintaining tissue-immune homeostasis and demonstrated how immune homeostasis links to tumor growth. 9 Previous studies demonstrated that skin migratory dendritic cells (DCs) have the ability to maintain tolerance to self-antigen and suppress ongoing immunity to foreign antigens. 10, 11 This ability depends upon the NF-κB-centered transcription of the 227 gene signature, including many tolerance-related genes, such as PD-L1, IDO and CD200. The most surprising observation in the study 9 is that in both human macrophages and mouse skin migratory DCs, the 227 gene signature overlaps with IFN-γ-induced transcripts. These findings indicate that IFN-γ is a sufficient instructive cue for homeostatic programming in mononuclear phagocytes and skin migratory DCs. These results reflect the homeostatic role of type I IFN. 12 Although it is not known whether tissues constitutively produce low levels of IFN-γ, tonic activity of the IFN-γ signaling pathway may be used to maintain tissue homeostasis. The essential part of IFN-γ homeostatic programs is balancing immunity and immune tolerance in healthy tissues. It is known that tumors co-opt tissue homeostatic programs controlled by mononuclear phagocytes and are IFN-γ dependent. The 227 gene homeostatic signature is enriched in multiple human primary cancers, and there is higher expression of the signature genes than is found in normal skin or nevi. The IFN-γ and 227 gene signatures are positively associated with melanoma survival. Thus, the homeostatic program appears to be tipped toward immune activation (for example, DC activation and cross-priming) in melanoma cancer patient pools. SOCS2 is a negative regulator of the IFN-γ signaling pathway and is one of the most highly differentially expressed genes in primary cutaneous melanoma. Furthermore, over activation of the immune system is well controlled in melanoma. DC-specific SOCS2 gene deletion promotes tumor rejection and adaptive T cell priming by DCs. Cumulatively, tumors are considered abnormal tissues that co-opt normal tissue physiology and alter immune surveillance and escape.
IFN-γ creates an inflamed tumor microenvironment, which is a prognostic biomarker for immunotherapy. 13 Thus, harnessing this mechanism for immunotherapy has a positive impact on antitumor responses. 14 However, chronic stimulation of IFN-γ (also type I IFN) results in potent immune suppression and is exemplified in tumor and chronic viral infection. In this case, STAT1 regulates an IFN-γ-mediated multigenic resistance program that includes T cell inhibitor receptors leading to T cell exhaustion and immune checkpoint blockade. 15 It is currently unclear how IFN-γ signaling has dual and opposite effects. The strength and duration of IFN-γ signaling are presumably the most important factors that govern the outcome of the pathway. Figure 1 provides a summary of the findings reported by Anadasabapathy's group and other researchers. 
